News & Updates

SARS-CoV-2 infection is associated with significantly higher incidence of benign prostatic hyperplasia (BPH) complications and addition of 5-alpha reductase inhibitor (5ARI) for combination therapy in male patients with lower urinary tract symptoms (LUTS) on alpha-1 adrenoreceptor blocker (AARB) monotherapy, a territory-wide retrospective cohort study in Hong Kong has shown.

A recent study has reported the prevalence of serious infection (SI) among patients with systemic lupus erythematosus (SLE) following treatment with rituximab (RTX).

Heart surgery during the COVID-19 pandemic took a turn for the worse, with higher cost and poorer survival regardless of people’s socioeconomic status, according to US data.